Erste Asset Management’s AbCellera Biologics ABCL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $224K | Hold |
62,000
| – | – | ﹤0.01% | 746 |
|
|
2025
Q1 | $143K | Hold |
62,000
| – | – | ﹤0.01% | 484 |
|
|
2024
Q4 | $185K | Hold |
62,000
| – | – | ﹤0.01% | 487 |
|
|
2024
Q3 | $162K | Hold |
62,000
| – | – | ﹤0.01% | 487 |
|
|
2024
Q2 | $179K | Hold |
62,000
| – | – | ﹤0.01% | 481 |
|
|
2024
Q1 | $278K | Hold |
62,000
| – | – | ﹤0.01% | 467 |
|
|
2023
Q4 | $368K | Hold |
62,000
| – | – | 0.01% | 449 |
|
|
2023
Q3 | $289K | Hold |
62,000
| – | – | 0.01% | 455 |
|
|
2023
Q2 | $408K | Hold |
62,000
| – | – | 0.01% | 437 |
|
|
2023
Q1 | $460K | Hold |
62,000
| – | – | 0.01% | 428 |
|
|
2022
Q4 | $623K | Hold |
62,000
| – | – | 0.01% | 408 |
|
|
2022
Q3 | $611K | Hold |
62,000
| – | – | 0.01% | 397 |
|
|
2022
Q2 | $627K | Hold |
62,000
| – | – | 0.01% | 406 |
|
|
2022
Q1 | $605K | Buy |
+62,000
| New | +$605K | 0.01% | 420 |
|